{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:57:20Z","timestamp":1793141840417,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","award":["SLS-971390"],"award-info":[{"award-number":["SLS-971390"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","award":["FoUI-981345"],"award-info":[{"award-number":["FoUI-981345"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010817","name":"Stiftelsen Kronprinsessan Margaretas Arbetsnamnd For Synskadade","doi-asserted-by":"publisher","award":["2022-017"],"award-info":[{"award-number":["2022-017"]}],"id":[{"id":"10.13039\/100010817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010810","name":"Ogonfonden","doi-asserted-by":"publisher","award":["2022-05-09"],"award-info":[{"award-number":["2022-05-09"]}],"id":[{"id":"10.13039\/100010810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ophtha.2023.10.026","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T05:01:54Z","timestamp":1698555714000},"page":"478-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Improved Staging of Ciliary Body and Choroidal Melanomas Based on Estimation of Tumor Volume and Competing Risk Analyses"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-8911","authenticated-orcid":false,"given":"Gustav","family":"St\u00e5lhammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Coupland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn G.","family":"Ewens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arupa","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3288-3632","authenticated-orcid":false,"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Damato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2023.10.026_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43856-022-00082-y","article-title":"Long-term relative survival in uveal melanoma: a systematic review and meta-analysis","volume":"2","author":"St\u00e5lhammar","year":"2022","journal-title":"Commun Med"},{"issue":"1","key":"10.1016\/j.ophtha.2023.10.026_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.ophtha.2023.10.026_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ajcp\/aqad029","article-title":"Multiorgan involvement of dormant uveal melanoma micrometastases in postmortem tissue from patients without coexisting macrometastases","volume":"160","author":"Gill","year":"2023","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.ophtha.2023.10.026_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12253-017-0355-7","article-title":"The results of stricter inclusion criteria in an immunomagnetic detection study of micrometastatic cells in bone marrow of uveal melanoma patients\u2014relevance for dormancy","volume":"25","author":"Eide","year":"2019","journal-title":"Pathol Oncol Res"},{"issue":"11","key":"10.1016\/j.ophtha.2023.10.026_bib5","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ophtha.2023.10.026_bib6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"22","key":"10.1016\/j.ophtha.2023.10.026_bib7","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.2012.45.2771","article-title":"Staging of ciliary body and choroidal melanomas based on anatomic extent","volume":"31","author":"Kujala","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"9010","key":"10.1016\/j.ophtha.2023.10.026_bib8","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic implications of monosomy 3 in uveal melanoma","volume":"347","author":"Prescher","year":"1996","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ophtha.2023.10.026_bib9","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","article-title":"Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma","volume":"119","author":"Onken","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.10.026_bib10","series-title":"AJCC Cancer Staging Manual","first-page":"813","article-title":"Uveal melanoma","author":"Kivel\u00e4","year":"2017"},{"issue":"4","key":"10.1016\/j.ophtha.2023.10.026_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamaophthalmol.2014.5395","article-title":"International validation of the American Joint Committee on Cancer\u2019s 7th edition classification of uveal melanoma","volume":"133","author":"Simpson","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2023.10.026_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.eye.6701806","article-title":"Calculated tumour volume as a prognostic parameter for survival in choroidal melanomas","volume":"20","author":"Kujala","year":"2006","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.ophtha.2023.10.026_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.eye.6700720","article-title":"Calculated tumour volume as a prognostic parameter for survival in choroidal melanomas","volume":"18","author":"Richtig","year":"2004","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.ophtha.2023.10.026_bib14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/aos.13668","article-title":"Tumour thickness, diameter, area or volume? The prognostic significance of conventional versus digital image analysis-based size estimation methods in uveal melanoma","volume":"96","author":"Arnljots","year":"2018","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2023.10.026_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/archopht.121.1.68","article-title":"Tumor basal area and metastatic death after proton beam irradiation for choroidal melanoma","volume":"121","author":"Li","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2023.10.026_bib16","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1167\/iovs.17-22255","article-title":"PRiMeUM: a model for predicting risk of metastasis in uveal melanoma","volume":"58","author":"Vaquero-Garcia","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ophtha.2023.10.026_bib17","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/bjophthalmol-2015-307057","article-title":"Concordant chromosome 3 results in paired choroidal melanoma biopsies and subsequent tumour resection specimens","volume":"99","author":"Coupland","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2023.10.026_bib18","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1167\/iovs.13-12195","article-title":"Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome","volume":"54","author":"Ewens","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ophtha.2023.10.026_bib19","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/IAE.0b013e31824d09a8","article-title":"Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases","volume":"32","author":"Shields","year":"2012","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.ophtha.2023.10.026_bib20","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1167\/iovs.16-20465","article-title":"Comparison of alternative tumor size classifications for posterior uveal melanomas","volume":"58","author":"Skinner","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ophtha.2023.10.026_bib21","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1038\/s41598-021-88390-6","article-title":"Estimation of the timing of BAP1 mutation in uveal melanoma progression","volume":"11","author":"Uner","year":"2021","journal-title":"Sci Rep"},{"issue":"9596","key":"10.1016\/j.ophtha.2023.10.026_bib22","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ophtha.2023.10.026_bib23","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/bmt.2009.359","article-title":"Regression modeling of competing risk using R: an in depth guide for clinicians","volume":"45","author":"Scrucca","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.ophtha.2023.10.026_bib24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","article-title":"Competing risk analysis using R: an easy guide for clinicians","volume":"40","author":"Scrucca","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ophtha.2023.10.026_bib25","first-page":"2","article-title":"cmprsk: Subdistribution analysis of competing risks","volume":"2","author":"Gray","year":"2022","journal-title":"Version R package version"},{"issue":"10","key":"10.1016\/j.ophtha.2023.10.026_bib26","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.ophtha.2013.03.012","article-title":"American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients","volume":"120","author":"Shields","year":"2013","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2023.10.026_bib27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1167\/iovs.14-15571","article-title":"The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma","volume":"56","author":"Bagger","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ophtha.2023.10.026_bib28","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ophtha.2015.12.024","article-title":"The Pediatric Choroidal and Ciliary Body Melanoma Study: a survey by the European Ophthalmic Oncology Group","volume":"123","author":"Al-Jamal","year":"2016","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2023.10.026_bib29","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ophtha.2004.11.063","article-title":"Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions","volume":"112","author":"Kujala","year":"2005","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2023.10.026_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ophtha.2021.11.018","article-title":"Adding The Cancer Genome Atlas chromosome classes to American Joint Committee on Cancer System offers more precise prognostication in uveal melanoma","volume":"129","author":"Gelmi","year":"2022","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2023.10.026_bib31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1167\/iovs.16-20212","article-title":"The prognostic value of AJCC staging in uveal melanoma is enhanced by adding chromosome 3 and 8q status","volume":"58","author":"Dogrusoz","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ophtha.2023.10.026_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/aos.15210","article-title":"A\u00a0prognostic classification system for uveal melanoma based on a combination of patient age and sex, the American Joint Committee on Cancer and The Cancer Genome Atlas models","volume":"101","author":"Gill","year":"2023","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2023.10.026_bib33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamaophthalmol.2019.5710","article-title":"Accuracy of The Cancer Genome Atlas classification vs American Joint Committee on Cancer classification for prediction of metastasis in patients with uveal melanoma","volume":"138","author":"Mazloumi","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"6009","key":"10.1016\/j.ophtha.2023.10.026_bib34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.ophtha.2023.10.026_bib35","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","article-title":"Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death","volume":"64","author":"Onken","year":"2004","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ophtha.2023.10.026_bib36","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastases","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ophtha.2023.10.026_bib37","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0161-6420(93)31470-3","article-title":"The prognostic value of tumor blood vessel morphology in primary uveal melanoma","volume":"100","author":"Folberg","year":"1993","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ophtha.2023.10.026_bib38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/PAT.0000000000000002","article-title":"BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma","volume":"45","author":"Shah","year":"2013","journal-title":"Pathology"},{"issue":"6","key":"10.1016\/j.ophtha.2023.10.026_bib39","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.eye.6702322","article-title":"Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study","volume":"21","author":"Callejo","year":"2007","journal-title":"Eye (Lond)"},{"issue":"8","key":"10.1016\/j.ophtha.2023.10.026_bib40","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/archopht.121.8.1163","article-title":"Comparison of clinical, echographic, and histopathological measurements from eyes with medium-sized choroidal melanoma in the collaborative ocular melanoma study: COMS report no. 21","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023007959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023007959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:23:24Z","timestamp":1773393804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642023007959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0161642023007959"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.10.026","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved Staging of Ciliary Body and Choroidal Melanomas Based on Estimation of Tumor Volume and Competing Risk Analyses","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}]}}